Document Detail


Targeting hepatoma using nitric oxide donor strategies.
MedLine Citation:
PMID:  22861189     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: The study evaluated the role of increased intracellular nitric oxide (NO) concentration using NO donors or stably NO synthase-3 (NOS-3) overexpression during CD95-dependent cell death in hepatoma cells. The expression of cell death receptors and caspase activation, RhoA kinase activity, NOS-3 expression/activity, oxidative/nitrosative stress, and p53 expression were analyzed. The antitumoral activity of NO was also evaluated in the subcutaneous implantation of NOS-3-overexpressing hepatoma cells, as well NO donor injection into wild-type hepatoma-derived tumors implanted in xenograft mouse models.
RESULTS: NO donor increased CD95 expression and activation of caspase-8 and 3 in HepG2, Huh7, and Hep3B cells. NOS-3 overexpression increased oxidative/nitrosative stress, p53 and CD95 expression, cellular Fas-associated death domain (FADD)-like IL-1beta converting enzyme (FLICE) inhibitory protein long (cFLIP(L)) and its short isoform (cFLIP(S)) shift, and cell death in HepG2 (4TO-NOS) cells. The inhibition of RhoA kinase and p53 knockdown using RNA interference reduced cell death in 4TO-NOS cells. The supplementation with hydrogen peroxide (H(2)O(2)) increased NOS-3 activity and cell death in 4TO-NOS cells. NOS-3 overexpression or NO donor injection into hepatoma-derived tumors reduced the size and increased p53 and cell death receptor expression in nude mice.
INNOVATION AND CONCLUSIONS: The increase of intracellular NO concentration promoted oxidative and nitrosative stress, Rho kinase activity, p53 and CD95 expression, and cell death in cultured hepatoma cells. NOS-3-overexpressed HepG2 cells or intratumoral NO donor administration reduced tumor cell growth and increased the expression of p53 and cell death receptors in tumors developed in a xenograft mouse model.
Authors:
Raúl González; Gustavo Ferrín; Patricia Aguilar-Melero; Isidora Ranchal; Clara I Linares; Rosario I Bello; Manuel De la Mata; Vladimir Gogvadze; José A Bárcena; José M Alamo; Sten Orrenius; Francisco J Padillo; Boris Zhivotovsky; Jordi Muntané
Related Documents :
10094819 - Expression of laminins 1 and 10 in carcinoma cells and comparison of their roles in cel...
22895829 - Insulin-like growth factor-1 protects against prion peptide-induced cell death in neuro...
22404919 - Cell ingression and apical shape oscillations during dorsal closure in drosophila.
2155419 - An immunohistochemical study of lung carcinomas using a monoclonal antibody which speci...
2158119 - Radiographic manifestations of primary bronchogenic carcinoma.
21462699 - Surface properties of bacteria from activated sludge in relation to bioflocculation.
23630579 - Hyperthermia-induced ndrg2 upregulation inhibits the invasion of human hepatocellular c...
18029299 - An amp nucleosidase gene knockout in escherichia coli elevates intracellular atp levels...
23335359 - Fate specification in the adult brain - lessons for eliciting neurogenesis from glial c...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-09-26
Journal Detail:
Title:  Antioxidants & redox signaling     Volume:  18     ISSN:  1557-7716     ISO Abbreviation:  Antioxid. Redox Signal.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-10     Completed Date:  2013-06-07     Revised Date:  2014-11-13    
Medline Journal Info:
Nlm Unique ID:  100888899     Medline TA:  Antioxid Redox Signal     Country:  United States    
Other Details:
Languages:  eng     Pagination:  491-506     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, CD95 / metabolism
Carcinoma, Hepatocellular / enzymology,  metabolism*,  pathology
Cell Line, Tumor
Genes, p53
Humans
Liver Neoplasms / enzymology,  metabolism*,  pathology
Mice
Nitric Oxide Donors / pharmacology*
Xenograft Model Antitumor Assays
rhoA GTP-Binding Protein / metabolism
Chemical
Reg. No./Substance:
0/Antigens, CD95; 0/Nitric Oxide Donors; 124671-05-2/RHOA protein, human; EC 3.6.5.2/rhoA GTP-Binding Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Atomic-Scale Morphology and Electronic Structure of Manganese Atomic Layers Underneath Epitaxial Gra...
Next Document:  Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane.